Airsculpt Technologies Inc(AIRS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.18 | Insider Own | 85.38% | Shs Outstand | 71.5M | Perf Week | 33.6% |
| Market Cap | 0.12B | Forward P/E | - | EPS next Y | 43.75% | Insider Trans | - | Shs Float | 10.5M | Perf Month | -5.11% |
| Enterprise Value | 0.17B | PEG | - | EPS next Q | -0.03 | Inst Own | 20.07% | Short Float | 28% | Perf Quarter | -65.28% |
| Income | -0.01B | P/S | 0.8 | EPS this Y | -60% | Inst Trans | -2.75% | Short Ratio | 3.27 | Perf Half Y | -37.69% |
| Sales | 0.15B | P/B | 1.14 | EPS next 5Y | 11.21% | ROA | -5.99% | Short Interest | 2.95M | Perf YTD | -15.66% |
| Book/sh | 1.47 | P/C | 6.4 | EPS past 3/5Y | 9.87% - | ROE | -11.98% | 52W High | -86% ($11.93) | Perf Year | -84.68% |
| Cash/sh | 0.26 | P/FCF | 158.42 | Sales past 3/5Y | -3.47% 19.32% | ROIC | -7.45% | 52W Low | 45.22% ($1.15) | Perf 3Y | -72.85% |
| Dividend Est. | - | EV/EBITDA | 15.49 | EPS Y/Y TTM | 26.89% | Gross Margin | 51.6% | Volatility(W/M) | 10.81% 9.62% | Perf 5Y | -89.04% |
| Dividend TTM | - | EV/Sales | 1.15 | Sales Y/Y TTM | -8.71% | Oper. Margin | -0.72% | ATR (14) | 0.16 | Perf 10Y | - |
| Dividend Ex-Date | 2022/8/25 | Quick Ratio | 0.79 | EPS Q/Q | -58.59% | Profit Margin | -7.79% | RSI (14) | 51 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.79 | Sales Q/Q | -2.53% | SMA20 | 12.01% ($1.49) | Beta | 2.3 | Target Price | $4.67 |
| Payout | - | Debt/Eq | 0.68 | Earnings | 2026/8/10 | SMA50 | -17.18% ($2.02) | Rel Volume | 1.71 | Prev Close | $1.44 |
| Employees | 363 | LT Debt/Eq | 0.5 | EPS/Sales Surpr. | -33.33% -2.8% | SMA200 | -46.52% ($3.12) | Avg Volume(3M) | 0.90M | Price | $1.67 |
| IPO | 2021/10/29 | Option/Short | Yes/Yes | Trades | 4872 | Volume | 1,548,442 | Change | 15.97% |
💎 This is a specialized medical company that offers premium body contouring and fat removal services. Leveraging its proprietary patented technology, AirSculpt®, the company provides safe and effective procedures without general anesthesia, actively targeting the high-end body contouring market in the US and other regions.
Over the past 1 year, on the lower side
86% below its 1-year high.
Traded more than usual. That is 171% of its average volume.
AIRS has weak earning power
Of every $100 in sales, $0.72 is lost.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -60.0% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $80. Peers typically go for $95.
Tap to view numbers
Results came in about as expected
Slight tendency to miss estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -89.0%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Short interest is a burden
28.0% of the float is sold short.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #38 of 48 in the industry
Based on market cap of $120M.
CYH#36 Community Health Systems Inc $340M PER 9.6 
WW#37 WW International Inc $150M PER - AIRS#38 Airsculpt Technologies Inc $120M PER - 
JYNT#39 Joint Corp $104M PER 28.2 
PARK#40 Park Dental Partners Inc $95M PER - 
FAQ
What kind of company is AIRS?
AIRS belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of AIRS?
The market cap of AIRS is approximately $120M, ranking 4,367 within its sector.
What is the 52-week high and low for AIRS?
AIRS has recorded a 52-week high of $11.93 and a low of $1.15.
